C07K 14/70592
Cd52
Official title: {cd52}
C07K14/70592 (Cd52) appears on 19 US grants and 33 published applications in this corpus.
Search patents in C07K- Granted patents
- 19
- Published applications
- 33
- Assignees
- 17
- Inventors
- 62
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 2 |
| 2018 | 1 | 3 |
| 2019 | 2 | 1 |
| 2020 | 2 | 5 |
| 2021 | 4 | 2 |
| 2022 | 0 | 8 |
| 2023 | 1 | 1 |
| 2024 | 2 | 2 |
| 2025 | 3 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for activation and expansion of natural killer cells and uses thereof18 Nov 2025US 12,473,336 B2Board of Regents, The University of Texas System
- Methods for activation and expansion of natural killer cells and uses thereof11 Nov 2025US 12,466,867 B2Board of Regents, The University of Texas System
- Chimeric antigen receptors targeting FLT313 May 2025US 12,296,012 B2Pfizer Inc.
- Expression of novel cell tags31 Dec 2024US 12,180,517 B2Precigen, Inc.
- Expression of novel cell tags13 Aug 2024US 12,060,585 B2Precigen, Inc.
- Gene editing systems and methods for reducing immunogenicity and graft versus host response4 Jun 2026US 2026/0152740 A1Correctsequence Therapeutics (Shanghai) Co., Ltd
- Expression of novel cell tags2 Oct 2025US 2025/0304930 A1Precigen, Inc.
- Genetically engineered antibody resistant (gear) cells for adoptive cellular therapy26 Jun 2025US 2025/0205282 A1VyGen-Bio, Inc.
- Membrane surface protein containing gpi anchor region13 Feb 2025US 2025/0049920 A1Shanghai Juncell Therapeutics Co., Ltd.
- Agent for activating a neuron1 Feb 2024US 2024/0033332 A1Kyoto University
Most cited
By later US patents
- Therapeutic antibodies5US 8,623,357 B2Isis Innovation Limited · 2014
- Expression of novel cell tags3US 11,118,168 B2Precigen, Inc. · 2021
- Soluble mediator2US 10,010,582 B2The Walter and Eliza Hall Institute of Medical Research · 2018
- Soluble mediator2US 9,585,969 B2The Walter and Eliza Hall Institute of Medical Research · 2017
- Method of treating sepsis by administering a soluble CD52 glycoprotein2US 9,778,269 B2The Walter and Eliza Hall Institute of Medical Research · 2017